drugset / Trial / NCT03079271
An Open Label Comparing the Short Term Efficacy of Lacrisert
NaSingle-groupOpen-labelSupportive care
Summary
To evaluate the short term effects of LACRISERT®. upon fluorescein corneal staining, tear osmolarity and surface topography in human subjects with dry eye disease.
Timeline
- Start
- 2016-11
- Primary completion
- 2017-06
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HYDROXYPROPYL CELLULOSE | Unknown | 5 mg | — |